ENDRA Life Sciences Announces At-Market Private Placement of Up to $14.4 Million to Launch Digital Asset Treasury Strategy Managed by Leading Crypto Asset Manager Arca

ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #MASH--ENDRA Life Sciences Inc. (Nasdaq: NDRA) ("ENDRA†or the "Company†monitoring of metabolic dysfunction associated liver disease ("MASLD† ) and metabolic dysfunction associated steatohepatitis ("MASH†), today announced an aggregate of $4.9 million in commitments for a private placement (the "Offering†) led by leading institutional and cryptocurrency investors. The proceeds will be used to launch a di. ...